icd 10 code for glycohemoglobin with eag

by Ms. Roxane Brakus 3 min read

What does hemoglobin A1C with eAG mean?

Glycated hemoglobin or A1C is a blood test that shows the average level of blood sugar over the previous 2 to 3 months. A1C is reported as a percent. eAG is reported in mg/dL (mmol/L). This is the same measurement used in home blood sugar meters. eAG is calculated directly from your A1C results.

What is the difference between eAG and HbA1c?

EAG is a measurement of your blood sugar over time and helps diabetics understand how well you are managing your blood sugar. It is based on your HbA1c results. While your glucose meter measures your blood sugar at the time of testing, EAG is the average of your blood glucose for the previous 2–3 months.

What ICD-10 code will cover A1C?

09: Other abnormal glucose.

What does diagnosis code R73 09 mean?

The ICD-10 code for prediabetes is R73. 09.

What is the normal range for eAG?

That corresponds to an A1C test result that's less than 7 percent. The ADA defines the following eAG ranges: Normal range: less than 114 mg/dL. Prediabetes range: greater than 114 mg/dL and less than 140 mg/dL.

What's the difference between A1C and glucose test?

The A1C test is a blood test that provides information about your average levels of blood glucose, also called blood sugar, over the past 3 months. The A1C test can be used to diagnose type 2 diabetes and prediabetes. The A1C test is also the primary test used for diabetes management.

What is R73 03?

ICD-10 code R73. 03 for Prediabetes is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .

What diagnosis will cover 83036?

Diabetes Hemoglobin A1c Testing Claims including procedure code 83036 or 83037 should include a line item with the resulting CPT procedure code below and be billed with a zero charge.

What is R53 83?

ICD-9 Code Transition: 780.79 Code R53. 83 is the diagnosis code used for Other Fatigue. It is a condition marked by drowsiness and an unusual lack of energy and mental alertness. It can be caused by many things, including illness, injury, or drugs.

What diagnosis will cover a hemoglobin A1c?

“HbA1c may be used for the diagnosis of diabetes, with values >6.5% being diagnostic.

What is the code for blood sugar test?

82947 Glucose; quantitative, blood (except reagent strip) 82948 Glucose; blood, reagent strip 82962 Glucose, blood by glucose monitoring device cleared by FDA for home use.

What is glycosylated hb ICD?

The glycosylated hemoglobin test shows what a person's average blood glucose level was for the 2 to 3 months before the test. This can help determine how well a person's diabetes is being controlled over time. /content/kidshealth/misc/medicalcodes/parents/articles/hba1c.

How do I convert my eAG to A1C?

The relationship between A1C and eAG is described by the formula 28.7 X A1C – 46.7 = eAG.

Which is more accurate HbA1c or fasting glucose?

However, in an epidemiological study, it has been concluded that FBS is more accurate than HbA1c. The best cutoff point for defining high HbA1c is another important issue. The Diabetes Control and Complications Trial suggested the value of 6% as HbA1c cut point.

Which is more accurate A1C or fasting glucose?

“While the American Diabetes Association guidelines specify that diabetes can be diagnosed based on fasting plasma glucose (FPG), the OGTT, or the A1c, our findings confirm that reliance on A1c remains the least reliable method for assessing diabetes risk.”

What is normal HbA1c value?

Your A1C Result A normal A1C level is below 5.7%, a level of 5.7% to 6.4% indicates prediabetes, and a level of 6.5% or more indicates diabetes.

When will the ICD-10-CM R73.9 be released?

The 2022 edition of ICD-10-CM R73.9 became effective on October 1, 2021.

What does it mean when you have high glucose levels?

Higher than normal amount of glucose (a type of sugar) in the blood. Hyperglycemia can be a sign of diabetes or other conditions.

How often should you check glycated hemoglobin?

Glycated hemoglobin in whole blood assesses glycemic control over a period of 4-8 weeks and appears to be the more appropriate test for monitoring a patient who is capable of maintaining long-term, stable control. Measurement may be medically necessary every 3 months to determine whether a patient's metabolic control has been on average within the target range. More frequent assessments, every 1-2 months, may be appropriate in the patient whose diabetes regimen has been altered to improve control or in whom evidence is present that intercurrent events may have altered a previously satisfactory level of control (for example, post-major surgery or as a result of glucocorticoid therapy). Glycated protein in serum/plasma assesses glycemic control over a period of 1-2 weeks. It may be reasonable and necessary to monitor glycated protein monthly in pregnant diabetic women. Glycated hemoglobin/protein test results may be low, indicating significant, persistent hypoglycemia, in nesidioblastosis or insulinoma, conditions which are accompanied by inappropriate hyperinsulinemia. A below normal test value is helpful in establishing the patient's hypoglycemic state in those conditions.

Why is glycated hemoglobin important?

Glycated hemoglobin/protein testing is widely accepted as medically necessary for the management and control of diabetes. It is also valuable to assess hyperglycemia, a history of hyperglycemia or dangerous hypoglycemia. Glycated protein testing may be used in place of glycated hemoglobin in the management of diabetic patients, and is particularly useful in patients who have abnormalities of erythrocytes such as hemolytic anemia or hemoglobinopathies.

What is the name of the blood test used to measure glucose levels in diabetics?

The management of diabetes mellitus requires regular determinations of blood glucose levels. Glycated hemoglobin/protein levels are used to assess long-term glucose control in diabetes. Alternative names for these tests include glycated or glycosylated hemoglobin or Hgb, hemoglobin glycated or glycosylated protein, and fructosamine.

Can glycated hemoglobin be analyzed?

When the glycated hemoglobin assay is initially performed in these patients, the laboratory may inform the ordering physician of a possible analytical interference. Alternative testing, including glycated protein, for example, fructosamine, may be indicated for the monitoring of the degree of glycemic control in this situation. It is therefore conceivable that a patient will have both a glycated hemoglobin and glycated protein ordered on the same day. This should be limited to the initial assay of glycated hemoglobin, with subsequent exclusive use of glycated protein. These tests are not considered to be medically necessary for the diagnosis of diabetes.

Expected Turnaround Time

Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.

Minimum Volume

Pediatric EDTA whole blood tubes may be used. Please place original labeled capillary tube in a labeled transport tube for shipment to the laboratory. ( Note: This volume does not allow for repeat testing.)

Container

Lavender-top (EDTA) tube, green-top (lithium heparin) tube, or gray-top (sodium fluoride) tube

Collection

The usual precautions in the collection of venipuncture samples should be observed. The sample must be free of clots. Samples with any hematocrit disorders can lead to erroneous results. Send the entire tube to the laboratory.

Limitations

Any cause of shortened erythrocyte survival will reduce exposure of erythrocytes to glucose with a consequent decrease in Hb A 1c (%). Causes of shortened erythrocyte lifetime might be hemolytic anemia or other hemolytic diseases, homozygous sickle cell trait, pregnancy, or recent significant or chronic blood loss.

Additional Information

Factors such as duration of diabetes, adherence to therapy, and age of patient should also be considered in assessing the degree of blood glucose control.

image